Meridian Life Science is proud to participate in Precision Oncology & Diagnostics 2025, an event developed with the editorial team of Precision Oncology News to spotlight the rapidly evolving field of precision oncology.
This meeting will bring together leaders across pharma, biotech, cancer centers, and the research community to discuss strategies and best practices for implementing molecularly guided cancer care.
Lina will be there to answer questions and share insights into how Meridian’s ambient-stable, lyophilized reagents for NGS library preparation are helping to remove cold-chain barriers, simplify workflows, and expand access to precision oncology testing.
This innovation delivers liquid-equivalent performance while supporting automation, reducing cost and environmental impact, and enabling reliable sequencing in settings with limited infrastructure. By stabilizing key steps across the library prep workflow, Meridian is advancing the democratization of NGS—empowering more labs to bring precision oncology to patients worldwide.
